Comparing Intrathecal Pain Pumps and Spinal Cord Stimulation Devices

Pain Pump vs Spinal Cord Stimulator: The Quick Difference

Pain pump vs spinal cord stimulator: a pain pump sends tiny doses of medication into the fluid around the spinal cord, while a spinal cord stimulator uses mild electrical signals to change how the nervous system processes pain.

Option

Best known for

What it delivers

Option 01

Intrathecal pain pump

Severe ongoing pain, cancer pain, or muscle spasticity; patients who cannot tolerate oral medicines

Medication through a catheter into the intrathecal space

Option 02

Spinal cord stimulator (SCS)

Nerve-related pain, including persistent back or leg pain after spine surgery, CRPS, and some neuropathy

Electrical stimulation through leads placed near the spinal cord

Neither option is a cure, and neither is automatically "better." The right choice depends on the source of pain, previous surgeries, daily function goals, medication tolerance, and results from a temporary trial. Both treatments are generally considered after conservative care has not provided enough relief.

I am Sonny Dosanjh, M.D., a board-certified Physical Medicine and Rehabilitation physician and fellowship-trained pain specialist. In evaluating pain pump vs spinal cord stimulator options, I help patients with chronic spine, nerve, and post-surgical pain understand which approach may fit their diagnosis, lifestyle, and goal of getting back to movement with less reliance on medication.

Pain pump versus spinal cord stimulator comparison infographic

Understanding Pain Pump vs Spinal Cord Stimulator Mechanisms

The simplest way to compare these devices is this:

  • A spinal cord stimulator changes pain signaling.
  • A pain pump changes medication delivery.

A spinal cord stimulator does not put medicine into the body. It uses implanted leads near the spinal cord to deliver controlled electrical pulses. These pulses alter how pain messages travel through the nervous system before the brain fully interprets them.

An intrathecal pain pump, also called an intrathecal drug delivery system, stores medication in an implanted reservoir. A catheter carries very small doses into the cerebrospinal fluid around the spinal cord. Because the medicine is delivered close to spinal pain receptors, the dose can often be much lower than an oral dose.

A helpful scientific overview of these device differences is available here: Scientific overview of device differences. For a deeper look at stimulation therapy, we also explain the process in our Spinal Cord Stimulator Complete Guide.

Feature

Spinal cord stimulator

Intrathecal pain pump

Main mechanism

Electrical neuromodulation
Targeted medication delivery

Implant location

Leads in the epidural space; pulse generator under the skin
Pump usually under abdominal skin; catheter into intrathecal space

Best pain match

Neuropathic pain, radicular pain, CRPS, post-surgical leg or back pain
Severe mixed pain, cancer pain, spasticity, medication-intolerant pain

Trial goal

Usually 50% or more pain relief and better function
Meaningful pain or spasticity reduction with tolerable side effects

Long-term upkeep

Charging or battery replacement, programming visits
Medication refills, dose adjustments, pump replacement

Medication exposure

No drug delivery
Lower dose than many oral regimens, but still medication-based

Neuromodulation and Electrical Impulse Therapy

Spinal cord stimulation is a form of neuromodulation. Thin leads are placed in the epidural space, near the dorsal columns of the spinal cord. These leads connect to a small pulse generator, usually implanted under the skin in the buttock, flank, or abdomen.

Traditional stimulation often creates a tingling sensation called paresthesia. Some patients like that sensation because it overlaps the painful area. Others find it distracting, especially when sitting, bending, or trying to sleep. Newer stimulation patterns, including high-frequency 10 kHz stimulation, can provide relief without that tingling feeling in many patients.

Research summarized in patient education sources suggests that about 50% to 60% of people using traditional low-frequency systems achieve major pain relief, while newer high-frequency systems may help 80% or more of appropriately selected patients reach substantial relief. Those numbers are encouraging, but they do not mean everyone gets that result. The trial period matters because your nervous system gets a vote.

At Medici Orthopaedics & Spine, we most often think about spinal cord stimulation for nerve-driven pain: burning, shooting, electric, radiating, or hypersensitive pain. If you are wondering whether nerve pain symptoms fit this treatment category, our guide Nerve Pain and Stimulators: Are You a Candidate is a useful next read.

Intrathecal Targeted Medication Delivery

A pain pump works very differently. The pump contains medication in a reservoir and sends it through a catheter into the intrathecal space, where cerebrospinal fluid surrounds the spinal cord.

Common intrathecal medications include:

  • Morphine, an opioid pain medication
  • Ziconotide, a non-opioid medication used for severe chronic pain
  • Baclofen, most often used for severe spasticity
  • Sometimes other medications or combinations, depending on the clinical situation and prescribing standards

Intrathecal delivery can be far more potent than oral dosing for certain drugs, sometimes described as 100 to 300 times more potent. That does not mean it is "stronger" in a reckless way. It means the medication is delivered closer to the target, so the total amount needed may be much smaller.

Because the medication bypasses the gastrointestinal tract and avoids the same first-pass processing as pills, some patients experience fewer whole-body side effects than they had with oral medication. However, a pain pump still uses medication, and side effects can still occur. Tiny dose, big responsibility.

For patients dealing with severe spasticity, we discuss this option further in Is the Baclofen Pump Right for You? A Snellville Doctor Weighs In.

Patient Candidacy and Disease Selection Criteria

Choosing between a pain pump and spinal cord stimulator starts with diagnosis, not device preference. The best device is not the newest, flashiest, or the one your neighbor liked. It is the one that matches your pain pattern, anatomy, medical history, and goals.

We typically consider:

  • Pain type: nerve, nociceptive, mixed, cancer-related, or spasticity-related
  • Pain location: back, leg, arm, widespread, or focal
  • Prior spine surgeries or implanted hardware
  • Imaging findings and spinal anatomy
  • Medication tolerance and opioid use
  • Infection risk and general surgical risk
  • Mental health screening and expectations
  • Ability to attend follow-up visits
  • Functional goals, such as walking, sleeping, working, or reducing medication

Psychological screening is not a judgment of whether pain is "real." Pain is real. Screening helps identify factors that can affect implant success, such as untreated depression, severe anxiety, substance-use risk, or unrealistic expectations. Implantable devices work best when we treat the whole person, not just the MRI.

Target Indications: Pain Pump vs Spinal Cord Stimulator Selection

Spinal cord stimulation is commonly considered for:

  • Failed back surgery syndrome, now often called persistent spinal pain syndrome
  • Chronic radicular leg pain or arm pain
  • Complex regional pain syndrome
  • Painful diabetic neuropathy in selected patients
  • Chronic neuropathic back or limb pain after conservative care fails
  • Some cases of non-surgical refractory back pain

A good SCS candidate often describes pain as burning, shooting, electrical, pins-and-needles, or radiating. If the pain travels down the leg after back surgery, SCS may be especially relevant. We explain candidacy in more detail here: Who Qualifies for a Spinal Cord Stimulator.

Pain pumps are more often considered for:

  • Severe chronic pain that has not responded to other care
  • Cancer-related pain
  • Severe spasticity, especially when oral baclofen causes side effects or is not enough
  • Mixed pain conditions where medication delivered near the spinal cord may help
  • Patients who cannot tolerate effective oral medication doses

Industry discussions of implantable pain technologies make the same broad distinction: SCS is usually matched to neuropathic pain, while intrathecal drug delivery is often used when targeted medication is the better tool. See Industry insights on device indications for a technology-focused overview.

Age alone does not automatically rule out either option. A patient in their 70s may still be a candidate if their health status, goals, anatomy, and follow-up ability support it. But age-related factors matter: skin healing, fall risk, cognitive ability to manage a controller, transportation for pump refills, and medication sensitivity all deserve careful review.

Efficacy in Failed Back Surgery Syndrome: Pain Pump vs Spinal Cord Stimulator

Failed back surgery syndrome, or persistent spinal pain syndrome, is one of the most common reasons patients ask about pain pump vs spinal cord stimulator options. We cover this condition here: What is Failed Back Surgery Syndrome and How Is It Treated.

For patients with persistent back and leg pain after lumbar surgery, SCS has some of the strongest evidence when the pain is neuropathic or radicular. It is especially relevant when there is no clear surgical target left, or when another spine surgery is unlikely to solve the pain generator.

Pain pumps may be considered when pain is severe, more widespread, medication-responsive, or when oral medications produce unacceptable side effects. They may also be part of a plan for patients whose pain is not well matched to stimulation.

A newer clinical trial design for persistent spinal pain syndrome is studying patient preference by allowing participants to test both SCS and intrathecal drug delivery before selecting a permanent implant. That study uses a 50% pain reduction threshold as a marker of trial success and includes functional outcome measures. You can review the trial listing here: Clinical study on post-surgical back pain trials.

For complex regional pain syndrome, SCS is often favored earlier than pain pumps when symptoms are neuropathic and limb-focused. Timing matters: long-standing CRPS can become harder to treat, so early evaluation with a pain specialist is important.

Evaluating Trial Protocols, Lead Options, and Modern Tech

temporary spinal stimulation lead trial equipment

One of the best things about both therapies is that they are usually tested before permanent implantation. We are big fans of "try before you implant." It is less catchy than "try before you buy," but much more medically accurate.

A successful trial usually means:

  • Pain decreases by about 50% or more
  • Function improves, not just the pain number
  • Sleep, walking, sitting, or activity tolerance improves
  • Side effects are manageable
  • The patient feels confident using the device or therapy
  • The care team agrees the result is clinically meaningful
implantable pain device trial process

Screening Trial Protocols and Patient Preferences

A spinal cord stimulator trial usually involves temporary leads placed through a needle into the epidural space. The leads are connected to an external generator worn outside the body. The trial often lasts 5 to 7 days, although protocols vary.

During the trial, patients track:

  • Pain scores
  • Walking or standing tolerance
  • Sleep
  • Medication use
  • Pain coverage
  • Comfort with stimulation settings
  • Any side effects or lead issues

Pain pump trials vary more. Some use a single intrathecal injection. Others use a temporary catheter and short infusion. In the clinical trial referenced above, the intrathecal trial uses a medication infusion over hours rather than a full week. The goal is to see whether targeted medication reduces pain or spasticity enough to justify a permanent pump.

Real patient experiences can be very different. In online chronic pain communities, some patients describe major improvement with SCS, such as around 60% pain relief, while others report little benefit from a pump or loss of benefit after hardware issues. These stories are useful because they remind us that outcomes vary. But they are not a substitute for a medical trial, imaging review, and individualized diagnosis.

Surgical Lead Selection and Innovations

SCS leads come in two main categories:

  • Percutaneous leads: placed through a needle, often used in trials and many permanent implants
  • Paddle leads: placed surgically, often requiring a small laminotomy, and sometimes used when lead stability is a major concern

A 2025 systematic review found that percutaneous leads are often preferred when patients do not have major anatomical abnormalities or previous spinal interventions at the target area. Paddle leads may be preferred when percutaneous placement is technically difficult, such as after prior spine surgery, or when a patient has failed a percutaneous approach. You can read the review here: Systematic review on percutaneous vs paddle leads.

Another study of 188 SCS systems found no major pain-control difference between percutaneous and paddle leads overall, but lead migration was higher in percutaneous leads: 10.83% versus 2.94% for surgical paddle leads. In patients who converted from percutaneous to paddle leads, average pain relief improved from 45% to 70%. See the study here: Clinical trial on paddle leads in neuropathic pain.

Modern SCS technology may include:

  • High-frequency stimulation
  • Paresthesia-free programming
  • Multiple stimulation waveforms
  • Rechargeable or non-rechargeable batteries
  • Position-responsive programming
  • Remote or app-supported adjustments in some systems

Modern pump technology may include:

  • Programmable dosing
  • Continuous baseline infusion
  • Clinician-adjusted dosing schedules
  • Patient-controlled bolus options in selected cases
  • Reservoirs that may last 1 to 3 months between refills, depending on dose and medication

Technology helps, but programming and follow-up are where the magic sauce lives. A great device with poor follow-up is like a sports car with no steering wheel.

Risks, Long-Term Maintenance, and Cost Considerations

Both devices are implanted medical systems, so both carry risks. The risk profile is different because one system uses electrical leads and a battery, while the other uses medication, a pump reservoir, and a catheter into spinal fluid.

Common SCS risks include:

  • Lead migration
  • Infection
  • Hardware malfunction
  • Pain at the implant pocket
  • Unwanted stimulation changes
  • Need for reprogramming
  • Battery replacement or revision surgery
  • Rare neurologic injury or bleeding

Published estimates commonly list SCS lead migration around 13.2%, infection around 3.4%, and hardware malfunction around 2.9%, though rates vary by study, technique, and follow-up duration.

Pain pump risks include:

  • Medication side effects
  • Overdose or withdrawal if delivery is interrupted
  • Catheter kinking, blockage, disconnection, or migration
  • Pump malfunction
  • Infection
  • Cerebrospinal fluid leak
  • Granuloma formation at the catheter tip
  • Refill errors, though these are uncommon with careful technique
  • Need for pump replacement when battery life ends

Cost is complicated. Insurance coverage, facility type, medication, follow-up frequency, and complications all matter. A small cost analysis found average procedural costs of about $105,234 for SCS and $79,333 for intrathecal pain pump implantation, with ongoing medication costs for pumps and annual maintenance costs for SCS. However, that study had a very small sample, so it should be viewed as a cost snapshot, not a universal price tag. You can review it here: Procedural cost analysis.

Patients who later need lumbar fusion should also be counseled carefully. Research has found that patients with an existing SCS or intrathecal pump who undergo posterior lumbar fusion may have higher revision rates than patients without these devices: 7.3% versus 5.0% at 1 year and 10.8% versus 7.0% at 2 years. Interestingly, removal versus retention of the device during fusion did not clearly change complication rates in that analysis. The practical takeaway: previous and future spine surgery plans matter.

Device Maintenance and Post-Operative Management

SCS maintenance usually involves:

  • Programming visits
  • Charging if the battery is rechargeable
  • Activity restrictions during early healing to reduce lead movement
  • Monitoring for infection or pocket pain
  • Battery replacement when needed

Rechargeable SCS batteries may last many years, sometimes 10 years or longer depending on use. Non-rechargeable batteries may need replacement sooner, often within several years. The tradeoff is simple: rechargeable devices require patient participation; non-rechargeable devices require less daily attention but may need more frequent replacement.

Pain pump maintenance usually involves:

  • Refills every 1 to 3 months, sometimes longer or shorter depending on medication and dose
  • Sterile refill technique
  • Dose adjustments
  • Monitoring for side effects
  • Pump replacement when battery life ends, often around 5 to 7 years depending on model and use
  • Emergency planning for withdrawal symptoms if medication delivery stops

For pain pumps, follow-up is not optional. If a pump runs empty, the problem can be serious, especially with baclofen or opioid therapy. For SCS, missed follow-up is usually less dangerous but can reduce benefit if programming is not optimized.

Frequently Asked Questions About Implantable Pain Devices

How do I know if a pain pump or spinal cord stimulator is right for me?

You start with a thorough pain evaluation. We look at your diagnosis, imaging, physical exam, prior treatments, surgical history, medication response, and pain pattern.

As a general rule:

  • If pain is mainly nerve-related, radiating, burning, or electrical, SCS may be the better first implant option.
  • If pain is severe, medication-responsive, cancer-related, spasticity-related, or not well controlled because oral medications cause side effects, a pain pump may be considered.
  • If you have had previous spine surgery, we pay close attention to scar tissue, hardware, and whether percutaneous or paddle leads are more realistic.
  • If you are older, we focus less on the number of birthdays and more on surgical risk, healing, cognition, mobility, and follow-up needs.

The trial period is often the deciding factor. If a temporary SCS trial gives you meaningful relief and better function, that is powerful information. If intrathecal medication produces better relief with tolerable side effects, that tells us something different. We do not need to guess when your body can help answer.

Does medication from a pain pump enter the bloodstream?

A pain pump delivers medication into the intrathecal space, not directly into the bloodstream. That is why much smaller doses can sometimes work compared with oral medication.

However, "not directly into the bloodstream" does not mean "never affects the body." Some medication can still be absorbed and metabolized, and side effects can still happen. Depending on the medication, possible side effects may include nausea, itching, dizziness, sleepiness, weakness, mood changes, swelling, urinary retention, or breathing problems.

The advantage is targeted delivery. The caution is that targeted medication is still medication.

What is the success rate of high-frequency spinal cord stimulation?

High-frequency SCS has shown strong outcomes in selected patients, with reports suggesting that 80% or more may achieve major relief in some groups. Traditional low-frequency systems are often reported closer to 50% to 60% for major pain relief.

That said, success should not be measured only by a pain score. We also care about:

  • Walking farther
  • Sleeping better
  • Sitting longer
  • Reducing medication reliance
  • Returning to hobbies
  • Improving mood and independence
  • Having fewer pain flares

A 50% pain reduction during trial is a common benchmark for moving forward, but we also ask, "What can you do now that you could not do before?" That question often matters more than the number.

Conclusion

When comparing pain pump vs spinal cord stimulator options, the best choice depends on the pain generator. Spinal cord stimulation is usually best matched to neuropathic pain, persistent post-surgical spine pain, CRPS, and selected neuropathy conditions. Intrathecal pain pumps are often considered for severe medication-responsive pain, cancer pain, and spasticity, especially when oral medications are ineffective or poorly tolerated.

At Medici Orthopaedics & Spine, our goal is to help patients in Snellville, Kennesaw, Buckhead, Marietta, Atlanta, and the Metro Atlanta area find the most effective, least invasive, least drug-dependent program medically available. Sometimes that includes implantable technology. Sometimes it includes physical therapy, injections, medication management, regenerative options, minimally invasive procedures, or other treatments working together.

If chronic spine or nerve pain is limiting your life, we can help you compare your options clearly and safely. Learn more about our approach to Pain Management, or explore our dedicated page on Spinal Cord Stimulation.

Tired of Feeling
Like Just Another
Chart?

At Medici, you’re more than your MRI.
We take time to hear your story, understand your pain, and create a plan that actually works for you.

Smiling woman with blonde hair wearing navy medical scrubs with hands behind her back.